This review highlights the need to address sex disparities in the prevalence and management of hypertension and hyperlipidemia to optimize stroke prevention in women.
Answers are grounded in this paper and cite their sources.
Potential sex disparities merit attention in stroke prevention; leaves open targeted trials on hypertension and hyperlipidemia management in women.
Stroke is a major cause of death and disability in adults worldwide. Prevention focused on modifiable risk factors, such as hypertension and hyperlipidemia, has shown them to be of significant importance in decreasing the risk of stroke. Multiple studies have brought to light the differences between men and women with regards to stroke and these risk factors. Women have a higher prevalence of stroke, mortality and disability and it has been shown that preventive and treatment options are not as comprehensive for women. Hence, it is of great necessity to evaluate and summarize the differences in gender and stroke risk factors in order to target disparities and optimize prevention, especially because women have a higher lifetime risk of stroke. The purpose of this review is to summarize sex differences in the prevalence of hypertension and hyperlipidemia. In addition, we will review the sex differences in stroke prevention effectiveness and adherence to blood pressure and cholesterol medications, and suggest future directions for research to reduce the burden of stroke in women.
No takes yet. Share an insight, caveat, or question.
Baghshomali et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: